434 related articles for article (PubMed ID: 10521980)
1. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
Haapamäki MM; Häggblom JO; Grönroos JM; Pekkala E; Alanen K; Nevalainen TJ
Hepatogastroenterology; 1999; 46(28):2273-7. PubMed ID: 10521980
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
3. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein.
Monajemi H; Meenan J; Lamping R; Obradov DO; Radema SA; Trown PW; Tytgat GN; Van Deventer SJ
Gastroenterology; 1996 Mar; 110(3):733-9. PubMed ID: 8608882
[TBL] [Abstract][Full Text] [Related]
6. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of CFTR expression but not SLC26A3 and SLC9A3 in ulcerative colitis.
Lohi H; Mäkelä S; Pulkkinen K; Höglund P; Karjalainen-Lindsberg ML; Puolakkainen P; Kere J
Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G567-75. PubMed ID: 12181169
[TBL] [Abstract][Full Text] [Related]
8. Mucosal and plasma prostaglandin E2 in ulcerative colitis.
Wiercinska-Drapalo A; Flisiak R; Prokopowicz D
Hepatogastroenterology; 1999; 46(28):2338-42. PubMed ID: 10521993
[TBL] [Abstract][Full Text] [Related]
9. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
Li MR; Jiang K; Zhang QY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
11. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
12. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
13. [Expression with TGFbeta1 in the patients with ulcerative colitis].
Wang YF; Wei B; Ouyang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):204-6. PubMed ID: 15807267
[TBL] [Abstract][Full Text] [Related]
14. Lipoxin biosynthesis in inflammatory bowel disease.
Mangino MJ; Brounts L; Harms B; Heise C
Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):84-92. PubMed ID: 16516812
[TBL] [Abstract][Full Text] [Related]
15. A murine model of ulcerative colitis: induced with sinusitis-derived superantigen and food allergen.
Yang PC; Wang CS; An ZY
BMC Gastroenterol; 2005 Mar; 5():6. PubMed ID: 15745456
[TBL] [Abstract][Full Text] [Related]
16. Plasma and mucosal prostaglandin E2 as a surrogate marker of ulcerative colitis activity.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Rocz Akad Med Bialymst; 2001; 46():60-8. PubMed ID: 11780581
[TBL] [Abstract][Full Text] [Related]
17. Increased oxidation of a chemical carcinogen, benzo(a)pyrene, by colon tissue biopsy specimens from patients with ulcerative colitis.
Mayhew JW; Lombardi PE; Fawaz K; Goldin B; Foster EA; Goldberg M; Sepersky R; Kellum JM; Gorbach SL
Gastroenterology; 1983 Aug; 85(2):328-34. PubMed ID: 6305757
[TBL] [Abstract][Full Text] [Related]
18. Expression of the Kp43 (CD 94) receptor by natural killer (NK) cells in ulcerative colitis.
del Mar Cabrera M; Valle J; Pajares JM; Romero I; Zomeño M; Maté J
Hepatogastroenterology; 2001; 48(41):1316-20. PubMed ID: 11677954
[TBL] [Abstract][Full Text] [Related]
19. Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis.
Bokarewa MI; Jin T; Tarkowski A
J Rheumatol; 2003 Aug; 30(8):1719-24. PubMed ID: 12913926
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis.
Izzo RS; Witkon K; Chen AI; Hadjiyane C; Weinstein MI; Pellecchia C
Am J Gastroenterol; 1992 Oct; 87(10):1447-52. PubMed ID: 1329495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
